Adequacy of treatment for serious mental illness in the United States

American Journal of Public Health

Volumn 92, Issue 1, 2002, Pages 92-98

  Wang, Philip S ^a,b,c   Demler, Olga ^a   Kessler, Ronald C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ANAMNESIS; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; NEGRO; PREVALENCE; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; QUALITY CONTROL; RACE DIFFERENCE; TREATMENT OUTCOME;

EID: 0036460450     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.92.1.92     Document Type: Article

References (66)

1. Kessler RC, Berglund PA, Zhao S, et al. The 12-month prevalence and correlates of serious mental illness (SMI). In: Manderscheid RW, Sonnenschein MA, eds. Mental Health, United States. Washington, DC: US Government Printing Office; 1996:59-70.
2. Kessler RC, Berglund PA, Walters EE, et al. A methodology for estimating the 12-month prevalence of serious mental illness. In: Manderscheid RW, Henderson RW, eds. Mental Health, United States 1998. Washington, DC: US Government Printing Office; 1998:99-109.
3. Rosenheck RA, Massari L, Frisman L. Who should receive high cost mental health treatment and for how long? Issues in the rationing of mental health care. Schizophr Bull. 1993;19:843-852.
4. Goldman HH. The obligation of mental health services to the least well off. Psychiatr Serv. 1999;50:659-663.
5. Rosenheck RA. Principles for priority setting in mental health services and their implications for the least well off. Psychiatr Serv. 1999;50:653-658.
6. Regier DA, Kaelber CT, Rae DS, et al. Limitations of diagnostic criteria and assessment instruments for mental disorders: Implications for research and policy. Arch Gen Psychiatry. 1998;55:109-115.
7. Spitzer RL. Diagnosis and need for treatment are not the same. Arch Gen Psychiatry. 1998;55:120.
8. National Advisory Mental Health Council. Health care reform for Americans with severe mental illness: report of the National Advisory Mental Health Council. Am J Psychiatry. 1993;150:1447-1465.
9. Katon W, Von Korff M, Lin E, et al. Collaborative management to achieve treatment guidelines: Impact on depression in primary care. JAMA. 1995;273: 1026-1031.
10. Katon W, Robinson P, Von Korff M, et al. A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry. 1996;53:924-932.
11. Katon W, Von KorffM, Lin E, et al. Stepped collaborative care for primary care patients with persistent symptoms of depression. Arch Gen Psychiatry. 1999;56:1109-1115.
12. Wells KB, Sherbourne C, Schoenbaum M, et al. Impact of disseminating quality improvement programs for depression in managed primary care. JAMA. 2000;283:212-220.
13. Melfi CA, Chawla AJ, Croghan TW, Hanna MP, Kennedy S, Sredl K. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Arch Gen Psychiatry. 1998;55:1128-1132.
14. Katz SJ, Kessler RC, Lin E, Wells KB. Medication management of depression in the United States and Ontario. J Gen Intern Med 1998;13:77-85.
15. Lehman AF, Steinwachs DM. Patterns of usual care for schizophrenia: Initial results from the Schizophrenia Patient Outcomes Research Team (PORT) client survey. Schizophr Bull. 1998;24:11-20.
16. Wells KB, Katon W, Rogers B, Camp P. Use of minor tranquilizers and antidepressant medications by depressed outpatients: Results from the Medical Outcomes Study. Am J Psychiatry. 1994;151:694-700.
17. Wang PS, Berglund PA, Kessler RC. Recent care of common mental disorders in the US: Prevalence and conformance with evidence-based recommendations. J Gen Intern Med. 2000;15:284-292.
18. Depression in Primary Care, Volume 2: Treatment of Major Depression. Rockville, Md: Agency for Health Care Policy and Research; 1993.
19. Practice Guideline for Major Depressive Disorder in Adults. Washington, DC: American Psychiatric Association; 1993.
20. Lehman AF, Steinwachs DM. Translating research into practice: The Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophr Bull. 1998;24:1-10.
21. Practice Guideline for the Treatment of Patients With Schizophrenia. Washington, DC: American Psychiatric Association; 1997.
22. Practice Guideline for the Treatment of Patients With Bipolar Disorder. Washington, DC: American Psychiatric Association; 1994.
23. Practice Guideline for the Treatment of Patients With Panic Disorder. Washington, DC: American Psychiatric Association; 1998.
24. Kessler RC, McGonagle KA, Zhao S, et al. Life-time and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994; 51:8-19.
25. Kessler RC, Little RJA, Groves RM. Advances in strategies for minimizing and adjusting for survey non-response. Epidemiol Rev. 1995;17:192-204.
26. Composite International Diagnostic Interview (CIDI), Version 10. Geneva, Switzerland: World Health Organization; 1990.
27. Spitzer RL, Williams JB, Gibbon M. Structured Clinical Interview for DSM-III-R. New York, NY: Biometrics Research Dept, New York State Psychiatric Institute; 1987.
28. Kessler RC, Wittchen HU, Abelson JM, et al. Methodological studies of the Composite International Diagnostic Interview (CIDI) in the US National Comorbidity Survey. Int J Methods Psychiatr Res. 1998;7: 33-55.
29. Kessler RC, Rubinow DR, Holmes C, Abelson JM, Zhao S. The epidemiology of DSM-III-R bipolar I disorder in a general population survey. Psychol Med. 1997;27:1079-1089.
30. Kendler KS, Gallagher TJ, Abelson JM, Kessler RC. Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffecfive psychosis as assessed in a US community sample: The National Comorbidity Survey. Arch Gen Psychiatry. 1996;53:1022-1031.
31. Kish L, Frankel MR. Inferences from complex samples. J R Stat Soc. 1974;36:1-37.
32. Kessler RC, Olfson M, Berglund PA. Patterns and predictors of treatment contact after first onset of psychiatric disorders. Am J Psychiatry. 1998;155:62-69.
33. Attkisson C, Cook J, Karno M, et al. Clinical services research. Schizophr Bull. 1992;18:561-626.
34. Outcasts on Main Street. Report of the Federal Task Force on Homelessness and Severe Mental Illness. Washington, DC: Interagency Council on Homelessness; 1992.
35. Cramer JA, Rosenheck R. Compliance with medication regimens for psychiatric and medical disorders. Psychiatr Serv. 1998;49:196-210.
36. Van Putten T. Why do schizophrenic patients refuse to take their drugs? Arch Gen Psychiatry. 1974;31:67-72.
37. Van Putten T, May PR. Subjective response as a predictor of outcome in pharmacotherapy: The consumer has a point. Arch Gen Psychiatry. 1978;35:477-480.
38. Leucht S, Pitschel-Walz G, Abraham D, Kissling W. Efficacy and extrapyramidal side effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo: A meta-analysis of randomized controlled trials. Schizophr Res. 1999;35:51-68.
39. Wahlbeck K, Cheine M, Essali A, Adams C. Evidence of clozapine's effectiveness in schizophrenia: A systematic review and meta-analysis of randomized trials. Am J Psychiatry. 1999;156:990-999.
40. Olfson M, Klerman GL, Pincus HA. The roles of psychiatrists in organized outpatient mental health settings. Am J Psychiatry. 1993;150:625-631.
41. Regier DA, Narrow WE, Rae DS, Manderscheid RW, Locke BZ, Goodwin FK. The de facto US mental and addictive disorders service system. Arch Gen Psychiatry. 1993;50:85-94.
42. Klinkman MS. Competing demands in psychosocial care: A model for the identification and treatment of mental disorders in primary care. Gen Hosp Psychiatry. 1997;19:98-111.
43. Williams JW. Competing demands: Does care for depression fit in primary care? J Gen Intern Med 1998;13:137-139.
44. Schwenk TL, Coyne JC, Fechner-Bates S. Differences between detected and undetected patients in primary care and depressed psychiatric patients. Gen Hosp Psychiatry. 1996;18:407-415.
45. Eisenberg L. Treating depression and anxiety in primary care. N Engl J Med. 1992;326:1080-1084.
46. Narrow WE, Regier DA, Rae DS, Manderscheid RW, Locke BZ. Use of services by persons with mental and addictive disorders. Arch Gen Psychiatry. 1993;50:95-107.
47. Baruch G, Gerber A, Fearon P. Adolescents who drop out of psychotherapy at a community-based psychotherapy center. Br J Med Psychol. 1998;71:233-245.
48. Ayanian JZ, Udvarhelyi IS, Gatsonis CA, Pashos CL, Epstein AM. Racial differences in the use of revascularization procedures after coronary angiography. JAMA. 1993;269:2642-2646.
49. Leaf PJ, Bruce ML, Tischler GL, Freeman DH, Weissman MM, Myers JK. Factors affecting utilization of specialty and general medical mental health services. Med Care. 1988;26:9-26.
50. Sellwood W, Tarrier N. Demographic factors associated with extreme non-compliance in schizophrenia. Soc Psychiatry Psychiatr Epidemiol. 1994;29:172-177.
51. Karno M, Edgerton RG. Perception of mental illness in a Mexican-American community. Arch Gen Psychiatry. 1969;20:233.
52. Cheung FK, Snowden LR. Community mental health and ethnic minority populations. Community Ment Health J. 1990;26:277-291.
53. Sheffler RM, Miller AG. Demand analysis of mental service use among ethnic subpopulations. Inquiry. 1989;26:202-215.
54. Marcos LR, Cancro R. Pharmacotherapy of Hispanic depressed patients: Clinical observations. Am J Psychother. 1982;36:505-512.
55. Karno M, Ross RN, Caper RA. Mental health roles of physicians in a Mexican-American community. Community Ment Health J 1969;5:62-69.
56. Fabrega H, Rubel AJ, Wallace CA. Working class Mexican psychiatric outpatients. Arch Gen Psychiatry. 1967;16:704-712.
57. Mellinger GD, Balter MB, Manheimer DI, Cisin IH, Parry HJ. Psychic distress, life crisis, and use of psychotherapeutic medications. Arch Gen Psychiatry. 1978;35:1045-1052.
58. National Center for Health Statistics. Office visits to psychiatrists: United States 1989-90. Adv Data Vital Health Stat. December 28, 1993; no. 237.
59. Knesper DJ, Wheeler JRC, Pagnucco DJ. Mental health services providers' distribution across counties in the United States. Am Psychol. 1984;39:1424-1434.
60. Regier DA, Hirschfeld RMA, Goodwin FK, Burke JD, Lazar JB, Judd LL. The NIMH Depression Awareness, Recognition, and Treatment Program: Structure, aims, and scientific basis. Am J Psychiatry. 1988;145: 1351-1357.
61. Carleton RA, Bazzarre T, Drake J, et al. Report of the expert panel on awareness and behavior change to the board of directors. Circulation. 1996;93:1768-1772.
62. Velicer WF, Hughes SL, Fava JL, Prochaska JO, DiClemente CC. An empirical typology of subjects within stage of change. Addict Behav. 1995;20:299-320.
63. Hirschfeld RMA, Keller MB, Panico S, et al. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA. 1997;277:333-340.
64. Wang P. Beyond screening: Improving the quality of treatment for depression. Harv Rev Psychiatry. 1999;7:177-182.
65. Consumer-Oriented Mental Health Report Card. Rockville, Md: Center for Mental Health Services, Substance Abuse and Mental Health Services Administration; 1996.
66. HEDIS 3.0: Narrative: What's in It and Why It Matters. Washington, DC: National Committee for Quality Assurance; 1997.